Advertisement
UK markets open in 3 hours

  • NIKKEI 225

    37,018.72
    -1,060.98 (-2.79%)
     

  • HANG SENG

    16,181.52
    -204.35 (-1.25%)
     

  • CRUDE OIL

    84.82
    +2.09 (+2.53%)
     

  • GOLD FUTURES

    2,404.30
    +6.30 (+0.26%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • Bitcoin GBP

    49,827.70
    -87.08 (-0.17%)
     

  • CMC Crypto 200

    1,277.00
    +391.46 (+42.55%)
     

  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     

  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

TCMD 7-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Alerts Tactile Systems Technology (TCMD) Investors to November 30th Application Deadline, Investors with Losses Should Contact the Firm

Newsfile Corp.
·2-min read

San Francisco, California--(Newsfile Corp. - November 23, 2020) - Hagens Berman urges Tactile Systems Technology (NASDAQ: TCMD) investors to submit their losses now. The firm has filed a securities fraud class action and certain investors may have valuable claims.

Class Period: May 7, 2018 - June 8, 2020

Lead Plaintiff Deadline: Nov. 30, 2020

Visit: www.hbsslaw.com/investor-fraud/TCMD

Contact An Attorney Now: TCMD@hbsslaw.com

844-916-0895

Hagens Berman's Tactile Securities Litigation:

Throughout the Class Period, Defendants allegedly misrepresented and concealed that: (1) while Tactile publicly touted a $4 plus billion or $5 plus billion market opportunity, in truth, the total addressable market for Tactile's medical devices was materially smaller; (2) to induce sales growth and share gains, Tactile engaged in illegal sales and marketing activities; and (3) Tactile's revenues were in part the product of unlawful conduct and thus unsustainable.

ADVERTISEMENT

The truth began to emerge on Mar. 20, 2019, when an amended federal Qui Tam complaint filed against Tactile was unsealed, which contained detailed allegations of illegal sales practices on the part of Tactile, causing the Company to submit fraudulent claims to Medicare and the VA.

Then, on Feb. 21, 2020, the court issued an order in the Qui Tam Action, denying Tactile's motion to dismiss in its entirety.

Finally, on June 8, 2020, research firm OSS Research published a scathing report about the Company, accusing Tactile of using a "'daisy-chaining' kickback scheme that has resulted in rampant overprescribing and rapid market share gains at the expense of patients, insurers and the public."

All told, these disclosures caused Tactile securities to decline precipitously, wiping out significant shareholder value.

If you are a TCMD investor, click here to discuss your legal rights with Hagens Berman. A copy of the Complaint can be obtained here.

"We're focused on investors' losses and proving Tactile deceived investors by engaging in illegal marketing schemes to induce sales growth," said Reed Kathrein, the Hagens Berman partner leading the investigation.

Whistleblowers: Persons with non-public information regarding Tactile should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email TCMD@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/68780